AAD Hair Loss Treatment: Minoxidil vs Finasteride Guide
Finasteride (Rx, $3-30/mo) blocks DHT; minoxidil 5% (OTC, $8-50/mo) boosts follicular blood flow. Compare FDA approval, cost, and access for androgenetic alopecia.
Finasteride vs Topical Minoxidil: Switching Between Them
Clinical comparison of finasteride and topical minoxidil for androgenetic alopecia, including when and how to switch between treatments safely.
Finasteride vs Tretinoin: Switching Between Them Safely
A clinical comparison of finasteride and tretinoin, including when and how to switch between these two drugs, what each treats, and key safety considerations.
Accutane (Isotretinoin) vs Spironolactone for Acne: Cost, Access, and Clinical Comparison
A head-to-head comparison of isotretinoin and spironolactone for acne treatment, covering cost, insurance access, clinical efficacy, side effects, and prescribing requirements.
Accutane (Isotretinoin) vs Spironolactone for Acne: Head-to-Head Efficacy Comparison
A clinical comparison of isotretinoin and spironolactone for acne treatment, covering efficacy data, side effects, patient selection, and when each drug is the better choice.
Accutane (Isotretinoin) vs Spironolactone for Acne: Side-Effect Profile Head-to-Head
A clinical comparison of isotretinoin and spironolactone side effects for acne treatment, including teratogenicity, hormonal effects, lab monitoring, and long-term safety data.
Oral Minoxidil vs Avodart (Dutasteride): Switching Between Them for Hair Loss
A clinical comparison of low-dose oral minoxidil and dutasteride (Avodart) for androgenetic alopecia, including when and how to switch between them safely.
Oral Minoxidil vs Topical Minoxidil: Switching Between Them
A clinical comparison of oral low-dose minoxidil and topical minoxidil 5% for hair loss, including evidence on efficacy, side effects, and how to safely switch between formulations.
Oral Minoxidil vs Tretinoin: Cost, Access, and Clinical Comparison
A head-to-head comparison of oral minoxidil and tretinoin covering cost, insurance access, prescribing pathways, clinical evidence, and which patients benefit most from each medication.
Oral Minoxidil vs Tretinoin: Head-to-Head Efficacy for Skin and Hair
A clinical comparison of oral minoxidil and topical tretinoin covering mechanisms, trial outcomes, side effects, and which patients benefit most from each therapy.
Topical Minoxidil vs Spironolactone: Switching Between Them
A clinical comparison of topical minoxidil and oral spironolactone for hair loss and skin conditions, including protocols for switching between them safely.
Tretinoin vs Avodart (Dutasteride): Side-Effect Profile Head-to-Head
A clinical comparison of tretinoin topical and dutasteride (Avodart) side effects, covering dermatologic irritation, sexual adverse events, systemic risk, and tolerability data from named trials.
Tretinoin vs Spironolactone for Acne: Cost, Access, and Clinical Comparison
A head-to-head look at tretinoin and spironolactone for acne treatment, comparing cost, insurance coverage, prescription access, efficacy data, and side-effect profiles.
Lunesta vs Dayvigo: Head-to-Head Efficacy Comparison
Comparing eszopiclone (Lunesta) and lemborexant (Dayvigo) for insomnia treatment. Evidence-based analysis of sleep onset, maintenance, next-day function, and safety profiles from clinical trials.
Dayvigo vs Trazodone Side Effects: Head-to-Head Comparison
Compare the side-effect profiles of Dayvigo (lemborexant) and trazodone for insomnia. Evidence from SUNRISE-1 and clinical data on tolerability, next-day function, and safety risks.
Dayvigo vs Trazodone: How to Switch Between Them Safely
Dayvigo vs trazodone: Dayvigo is an FDA-approved orexin blocker with SUNRISE trial data; trazodone is a low-cost off-label sedative. No cross-taper needed.
Eszopiclone vs Zolpidem: Side Effects Compared
Eszopiclone causes an unpleasant taste in up to 34% of users; zolpidem carries higher next-morning impairment risk. Both share a 2019 FDA boxed warning.
Synthroid vs Methimazole (Tapazole): Cost and Access Head-to-Head
Compare Synthroid (levothyroxine) and Methimazole (Tapazole) side by side on price, insurance coverage, generic availability, pharmacy access, and clinical role in thyroid disorders.
Oral Estradiol vs Vaginal Estradiol: Cost, Access, and Clinical Comparison
A head-to-head comparison of oral estradiol and vaginal estradiol covering cost, insurance access, systemic exposure, clinical efficacy, and prescribing considerations for menopausal hormone therapy.
Oral Estradiol vs Vaginal Estradiol: Head-to-Head Efficacy Comparison
Evidence-based comparison of oral estradiol and vaginal estradiol, covering efficacy for vasomotor symptoms, genitourinary syndrome of menopause, systemic absorption, safety profiles, and clinical guidance on choosing the right route.
Estradiol Progesterone Cost - Patch vs Pill Prices Compared
Generic estradiol patch runs $25-60 per month; oral micronized progesterone about $15. Most women with a uterus need both; both are widely covered by insurance.
Estradiol Patch vs Prometrium: Head-to-Head Efficacy Comparison
Clinical comparison of estradiol transdermal patches and micronized progesterone (Prometrium) for menopausal hormone therapy, including efficacy data from WHI and PEPI trials.
Estradiol Patch vs Prometrium: Side-Effect Profile Head-to-Head
A clinical comparison of the side-effect profiles of transdermal estradiol patches and oral micronized progesterone (Prometrium) in menopausal hormone therapy.
Estradiol Patch vs Prometrium: Switching Between Them
A clinical comparison of estradiol transdermal patches and micronized progesterone (Prometrium), including when and how to switch between them safely during menopause hormone therapy.
Estradiol Patch vs Vaginal Estradiol: Head-to-Head Efficacy Compared
A clinical comparison of estradiol patch (transdermal) and vaginal estradiol for menopausal symptoms, covering efficacy data, systemic absorption, symptom relief, and which route suits different patients.
Estradiol vs Progesterone Cost: Monthly Price Comparison
Generic estradiol runs $4 to $30 a month, micronized progesterone $10 to $45. Both are covered by most insurance and stocked at major pharmacies.
Oral Micronized Progesterone vs Oral Estradiol: Side-Effect Profile Head-to-Head
A clinical comparison of the side-effect profiles of oral micronized progesterone (Prometrium) and oral estradiol, including cardiovascular risk, breast cancer data, metabolic effects, and tolerability differences from PEPI, WHI, and current guidelines.
Oral Micronized Progesterone vs Vaginal Estradiol: Head-to-Head Efficacy
A clinical comparison of oral micronized progesterone (Prometrium) and vaginal estradiol for women's HRT, covering efficacy, safety, indications, and when to use each hormone.
Oral Micronized Progesterone vs Vaginal Estradiol: Switching Between Them
A clinical comparison of oral micronized progesterone (Prometrium) and vaginal estradiol, including when and how to switch between them safely.
Addyi vs Vyleesi: Cost and Access Head-to-Head Comparison
A detailed comparison of Addyi (flibanserin) and Vyleesi (bremelanotide) covering pricing, insurance coverage, pharmacy access, and clinical value for HSDD treatment.
Addyi vs Vyleesi: Head-to-Head Efficacy for HSDD
A clinical comparison of flibanserin (Addyi) and bremelanotide (Vyleesi) for hypoactive sexual desire disorder, including trial data, dosing, side effects, and practical guidance.
Genetics and Family History in Established Cardiovascular Disease
How inherited risk shapes outcomes in patients with established cardiovascular disease, from polygenic risk scores to familial hypercholesterolemia screening and targeted pharmacotherapy.
Testosterone Deficiency Diagnosis: Endocrine Society Guideline
Diagnosis requires two morning total testosterone results below 300 ng/dL, confirmed symptoms, then LH and FSH to classify primary vs secondary hypogonadism.
Male Hypogonadism: Emerging Research and Trials to Watch
A clinical review of the most promising emerging research, active clinical trials, and next-generation therapies for male hypogonadism, including oral testosterone, selective androgen receptor modulators, and kisspeptin-based treatments.
Male Hypogonadism: Genetics and Family History
How genetics and family history influence male hypogonadism risk, which heritable conditions cause low testosterone, and what genetic testing and screening options exist for men and their families.
Male Hypogonadism Guidelines Compared: ADA, AACE, Endocrine Society, AUA, and EAU
A side-by-side comparison of the major clinical practice guidelines for diagnosing and treating male hypogonadism, including testosterone thresholds, testing protocols, and treatment recommendations from the Endocrine Society, AUA, AACE, ADA, and EAU.
Low Testosterone and Mental Health: Depression, Anxiety Risk
Testosterone under 300 ng/dL overlaps with depression and anxiety symptoms; men with low T face 2-4x higher depression rates, per Endocrine Society criteria.
Male Hypogonadism Monitoring Schedule: When to Test and What to Track on TRT
A detailed, guideline-based monitoring schedule for men on testosterone replacement therapy (TRT), covering baseline labs, 3-month check-ins, 6-month evaluations, and annual assessments per Endocrine Society and AUA recommendations.
Male Hypogonadism in Special Populations
Evidence-based guide to diagnosing and treating male hypogonadism in special populations including obesity, type 2 diabetes, HIV, opioid users, older men, chronic kidney disease, and cancer survivors.
Menopause Comorbidities: Conditions That Overlap With the Menopausal Transition
A guide to the most common comorbidities linked to menopause, including cardiovascular disease, osteoporosis, type 2 diabetes, depression, and genitourinary syndrome, with evidence-based treatment approaches.
Menopause Emerging Research and Trials to Watch
A clinical review of the most promising menopause research in 2024-2026, including NK3 receptor antagonists, estetrol, microbiome therapies, and updated guideline shifts.
Menopause Guidelines Compared: ADA, AACE, Endocrine Society, USPSTF, and NAMS
A side-by-side comparison of major society guidelines for menopause diagnosis, hormone therapy, and long-term management from NAMS, the Endocrine Society, AACE, ADA, and USPSTF.
Genetics and Family History Behind Menopause-Related Weight Gain
How your genes and family history influence weight gain during menopause, including key genetic variants, heritability estimates, and evidence-based strategies to manage hereditary risk.
Menopause-Related Weight Gain Guidelines Compared: ADA, AACE, Endocrine Society, NAMS, and USPSTF
A side-by-side comparison of major society guidelines on managing menopause-related weight gain, including pharmacotherapy thresholds, HRT recommendations, and lifestyle interventions from ADA, AACE, the Endocrine Society, NAMS, and USPSTF.
Menopause-Related Weight Gain and Mental Health: How Depression, Anxiety, and Stress Drive Midlife Body Composition Changes
Explore the bidirectional relationship between menopause-related weight gain and mental health conditions including depression, anxiety, and emotional eating, with evidence-based treatment strategies.
Metabolic Syndrome Monitoring Schedule: Exact Tests, Intervals, and Targets
A guideline-backed monitoring schedule for metabolic syndrome, including lab tests, visit intervals, and clinical targets from ADA, AACE, and the Endocrine Society.
Metabolic Syndrome Nutrition and Lifestyle Protocols: Evidence-Based Strategies
Evidence-based nutrition and lifestyle protocols for metabolic syndrome, including dietary patterns, exercise prescriptions, and behavioral interventions backed by major clinical trials and society guidelines.
NAFLD / MASLD Genetics and Family History
How genetic variants like PNPLA3, TM6SF2, and HSD17B13 influence NAFLD/MASLD risk, and what family history means for screening, diagnosis, and treatment decisions.
NAFLD / MASLD Exact Monitoring Schedule
Evidence-based monitoring schedule for NAFLD and MASLD, including lab frequency, imaging intervals, fibrosis staging, and when to refer to hepatology.
NAFLD / MASLD Nutrition and Lifestyle Protocols
Evidence-based nutrition and lifestyle interventions for metabolic-associated steatotic liver disease (MASLD/NAFLD), including dietary patterns, exercise prescriptions, and weight-loss targets backed by major clinical trials and society guidelines.
Exercise Prescription for Obesity (BMI ≥30): Evidence-Based Protocols and Guidelines
A guide to exercise prescription for adults with obesity (BMI ≥30), covering AHA, ACSM, and Endocrine Society recommendations with specific protocols, doses, and trial data.
Obesity (BMI ≥30) Exact Monitoring Schedule
A guideline-backed monitoring schedule for adults with obesity (BMI ≥30), covering lab work, vitals, metabolic panels, and follow-up intervals during pharmacotherapy and lifestyle intervention.
Obesity Treatment in Special Populations: Evidence-Based Approaches for Complex Patients
How obesity management differs for older adults, adolescents, pregnant patients, and those with CKD, diabetes, or psychiatric conditions. Guideline-backed strategies with trial data.
Obesity Treatment Algorithm: A Line-by-Line Guide to Evidence-Based Therapy
Step-by-step obesity treatment algorithm organized by line of therapy, from lifestyle intervention through pharmacotherapy and metabolic surgery, based on ADA, AACE, and Endocrine Society guidelines.
Obstructive Sleep Apnea Comorbidities: The Conditions That Overlap With OSA
Obstructive sleep apnea rarely travels alone. Learn which comorbidities overlap most with OSA, how they interact, and what the clinical evidence says about managing them together.
Obstructive Sleep Apnea Genetics and Family History: What Runs in Your Family
Obstructive sleep apnea has a strong genetic component. Learn how family history, inherited craniofacial traits, and specific gene variants increase OSA risk, and what screening steps to take.
Testosterone Therapy and Severe Untreated Sleep Apnea
Endocrine Society advises against testosterone therapy in untreated severe OSA. See this rule alongside ADA, AACE, AASM, and USPSTF guidance compared.
PCOS Emerging Research and Trials to Watch in 2026
A guide to the latest PCOS research, including GLP-1 receptor agonists, ovasitol, anti-Müllerian hormone diagnostics, and ongoing clinical trials for polycystic ovary syndrome.
Perimenopause Caregiver and Family Resources
Evidence-based guide for caregivers and families supporting someone through perimenopause, covering communication strategies, treatment literacy, mental health support, and clinical resources.
Perimenopause Diagnostic Algorithm: A Step-by-Step Clinical Guide
A step-by-step perimenopause diagnostic algorithm covering STRAW+10 staging, lab workup, differential diagnosis, and treatment initiation based on major society guidelines.